Methodology

Showing 9 of 0 results

• Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLC

  ISPOR

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • Non-small cell lung cancer
• Characterisation of oncology EHR-derived real-world data in the UK, Germany, and Japan

  ESMO Real-World Data and Digital Oncology

  • Real-world evidence
  • Publication summary
  • Publications
  • Data science
  • Methodology
  • HTA and market access
• Measurement error and bias in real-world oncology endpoints when constructing external control arms

  Frontiers in Drug Safety and Regulation

  • Publication summary
  • Publications
  • Methodology
  • Multiple myeloma
• An evaluation of patient activity definitions and informative censoring in analyses of real-world overall survival in electronic health records (EHR) in the United States

  ISPE Annual Conference

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
• Assessing the potential value of commercial mortality data combined with publicly available death data for pharmacoepidemiology research

  ISPE Annual Conference

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
• Assessment of the application of a 90-day-gap rule for mitigating frontline treatment sequence misclassification in electronic health records in the United States

  ISPE Annual Conference

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
• Assessing real-world data from electronic health records for health technology assessment: The SUITABILITY checklist: a good practices report of an ISPOR task force

  Value in Health

  • Publication summary
  • Publications
  • Data science
  • Methodology
  • Regulatory
  • HTA and market access
  • AP - Blythe Adamson, MPH, PhD
• Response- and progression-based endpoints in trial and observational cohorts of patients With NSCLC

  JAMA Network Open

  • Publication summary
  • Publications
  • Methodology
  • Non-small cell lung cancer
• Performance assessment of a disease-agnostic treatment sequencing heuristic for deriving line of therapy in a real-world, rare, multi-tumor cohort across tumor mutational burden status

  Poster presented at: ISPOR US 2024; May 5-8, 2024; Atlanta, GA

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology